Dr. David Schubert to advise Nemus on neuroprotection and CNS applications of the company’s proprietary cannabinoid portfolio. COSTA MESA, CA. , March 21, 2018 (GLOBE NEWSWIRE) — Nemus Bioscience, Inc. (OTCQB: NMUS), focused on the development of cannabinoid -based therapeutics to … Read More
The post Prominent Salk Institute Neuroscientist Joins Nemus Bioscience as Scientific Consultant appeared first on Dagga Magazine.